SSeCKS sequesters cyclin D1 in glomerular parietal epithelial cells and influences proliferative injury in the glomerulus

Laboratory Investigation

Volumn 92, Issue 4, 2012, Pages 499-510

  Burnworth, Bettina ^a   Pippin, Jeff ^a   Karna, Prasanthi ^a   Akakura, Shin ^b   Krofft, Ron ^a   Zhang, Guoqiang ^a   Hudkins, Kelly ^c   Alpers, Charles E ^a,c   Smith, Kelly ^c   Shankland, Stuart J ^a   Gelman, Irwin H ^b   Nelson, Peter J ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

cell cycle; glomerulonephritis; glomerulopathy; parietal epithelial cell; podocyte; proliferation; stem cell

Indexed keywords

CYCLIN D1; PROTEIN KINASE C; SRC SUPPRESSED PROTEIN KINASE C SUBSTRATE; TRANSCRIPTION FACTOR PAX8; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CYCLE S PHASE; CELL GROWTH; CELL INTERACTION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; EMBRYO CELL; GLOMERULAR FILTRATION BARRIER; GLOMERULAR PARIETAL EPITHELIAL CELL; GLOMERULOPATHY; GLOMERULUS; GLOMERULUS EPITHELIUM; IN VIVO STUDY; KIDNEY INJURY; MALE; MOUSE; NEPHRITIS; NEPHROTOXICITY; NONHUMAN; PHENOTYPE; PODOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEINURIA; UPREGULATION;

A KINASE ANCHOR PROTEINS; ANIMALS; CELL CYCLE PROTEINS; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN D1; KIDNEY GLOMERULUS; MALE; MICE; MICE, KNOCKOUT; PHENOTYPE; PODOCYTES;

EID: 84859302593     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2011.199     Document Type: Article

References (38)

1. Romagnani P. Toward the identification of a 'renopoietic system'? Stem Cells 2009;27:2247-2253.
2. Lasagni L, Romagnani P. Glomerular epithelial stem cells: the good, the bad, and the ugly. J Am Soc Nephrol 2010;21:1612-1619.
3. Appel D, Kershaw DB, Smeets B, et al. Recruitment of podocytes from glomerular parietal epithelial cells. J Am Soc Nephrol 2009;20:333-343.
4. Smeets B, Uhlig S, Fuss A, et al. Tracing the origin of glomerular extracapillary lesions from parietal epithelial cells. J Am Soc Nephrol 2009;20:2604-2615.
5. Smeets B, Angelotti ML, Rizzo P, et al. Renal progenitor cells contribute to hyperplastic lesions of podocytopathies and crescentic glomerulonephritis. J Am Soc Nephrol 2009;20:2593-2603.
6. He S, Nakada D, Morrison SJ. Mechanisms of stem cell self-renewal. Annu Rev Cell Dev Biol 2009;25:377-406.
7. Petermann A, Hiromura K, Pippin J, et al. Differential expression of d-type cyclins in podocytes in vitro and in vivo. Am J Pathol 2004;164:1417-1424. (Pubitemid 38387807)
8. Marshall CB, Shankland SJ. Cell cycle regulatory proteins in podocyte health and disease. Nephron Exp Nephrol 2007;106:e51-e59. (Pubitemid 47202763)
9. Gelman IH. The role of SSeCKS/gravin/AKAP12 scaffolding proteins in the spatiotemporal control of signaling pathways in oncogenesis and development. Front Biosci 2002;7:d1782-d1797.
10. Carnegie GK, Means CK, Scott JD. A-kinase anchoring proteins: from protein complexes to physiology and disease. IUBMB Life 2009;61:394-406.
11. Lin X, Nelson PJ, Frankfort B, et al. Isolation and characterization of a novel mitogenic regulatory gene, 322, which is transcriptionally suppressed in cells transformed by src and ras. Mol Cell Biol 1995;15:2754-2762.
12. Lin X, Tombler E, Nelson PJ, et al. A novel src- and ras-suppressed protein kinase C substrate associated with cytoskeletal architecture. J Biol Chem 1996;271:28430-28438. (Pubitemid 26374662)
13. 1→S progression by controlling the expression and cellular compartmentalization of cyclin D. Mol Cell Biol 2000;20:7259-7272.
14. Lin X, Gelman IH. Calmodulin and cyclin D anchoring sites on the Src-suppressed C kinase substrate, SSeCKS. Biochem Biophys Res Commun 2002;290:1368-1375. (Pubitemid 34687408)
15. Nelson PJ, Daniel TO. Emerging targets: molecular mechanisms of cell contact-mediated growth control. Kidney Int 2002;61(Suppl):S99-105.
16. Nelson PJ, Gelman IH. Cell-cycle regulated expression and serine phosphorylation of the myristylated protein kinase C substrate, SSeCKS: correlation with culture confluency, cell cycle phase and serum response. Mol Cell Biochem 1997;175:233-241. (Pubitemid 27453357)
17. Griner EM, Kazanietz MG. Protein kinase C and other diacylglycerol effectors in cancer. Nat Rev Cancer 2007;7:281-294. (Pubitemid 46480971)
18. Nelson PJ, Moissoglu K, Vargas Jr J, et al. Involvement of the protein kinase C substrate, SSeCKS, in the actin-based stellate morphology of mesangial cells. J Cell Sci 1999;112(Part 3):361-370. (Pubitemid 29080658)
19. Ohse T, Chang AM, Pippin JW, et al. A new function for parietal epithelial cells: a second glomerular barrier. Am J Physiol Renal Physiol 2009;297:F1566-F1574.
20. Barisoni L, Madaio MP, Eraso M, et al. The kd/kd mouse is a model of collapsing glomerulopathy. J Am Soc Nephrol 2005;16:2847-2851. (Pubitemid 44743481)
21. Ohse T, Vaughan MR, Kopp JB, et al. De novo expression of podocyte proteins in parietal epithelial cells during experimental glomerular disease. Am J Physiol Renal Physiol 2010;298:F702-F711.
22. Akakura S, Huang C, Nelson PJ, et al. Loss of the SSeCKS/Gravin/ AKAP12 gene results in prostatic hyperplasia. Cancer Res 2008;68: 5096-5103.
23. Ohse T, Pippin JW, Vaughan MR, et al. Establishment of conditionally immortalized mouse glomerular parietal epithelial cells in culture. J Am Soc Nephrol 2008;19:1879-1890.
24. Pippin JW, Brinkkoetter PT, Cormack-Aboud FC, et al. Inducible rodent models of acquired podocyte diseases. Am J Physiol Renal Physiol 2009;296:F213-F229.
25. Ohse T, Pippin JW, Chang AM, et al. The enigmatic parietal epithelial cell is finally getting noticed: a review. Kidney Int 2009;76: 1225-1238.
26. Schutze S, Machleidt T, Kronke M. The role of diacylglycerol and ceramide in tumor necrosis factor and interleukin-1 signal transduction. J Leukocyte Biol 1994;56:533-541. (Pubitemid 24348808)
27. Vielhauer V, Stavrakis G, Mayadas TN. Renal cell-expressed TNF receptor 2, not receptor 1, is essential for the development of glomerulonephritis. J Clin Invest 2005;115:1199-1209. (Pubitemid 40629038)
28. Bruggeman LA, Drawz PE, Kahoud N, et al. TNFR2 interposes the proliferative and NF-kappaB-mediated inflammatory response by podocytes to TNF-alpha. Lab Invest 2011;91:413-425.
29. Akakura S, Bouchard R, Bshara W, et al. Carcinogen-induced squamous papillomas and oncogenic progression in the absence of the SSeCKS/ AKAP12 metastasis suppressor correlates with FAK upregulation. Int J Cancer 2011;129:2025-2031.
30. Wiggins RC. The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int 2007;71:1205-1214. (Pubitemid 46884251)
31. Ophascharoensuk V, Pippin JW, Gordon KL, et al. Role of intrinsic renal cells versus infiltrating cells in glomerular crescent formation. Kidney Int 1998;54:416-425. (Pubitemid 28357404)
32. Albaqumi M, Soos TJ, Barisoni L, et al. Collapsing glomerulopathy. J Am Soc Nephrol 2006;17:2854-2863. (Pubitemid 44484675)
33. Barisoni L, Nelson PJ. Collapsing glomerulopathy: an inflammatory podocytopathy? Curr Opin Nephrol Hypertens 2007;16:192-195. (Pubitemid 46608526)
34. Bruggeman LA, Nelson PJ. Controversies in the pathogenesis of HIV-associated renal diseases. Nat Rev 2009;5:574-581.
35. Akakura S, Nochajski P, Gao L, et al. Rb-dependent cellular senescence, multinucleation and susceptibility to oncogenic transformation through PKC scaffolding by SSeCKS/AKAP12. Cell Cycle 2010;9: 4656-4665.
36. Lee SW, Kim WJ, Choi YK, et al. SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier. Nat Med 2003;9: 900-906. (Pubitemid 36889933)
37. Su B, Zheng Q, Vaughan MM, et al. SSeCKS metastasis-suppressing activity in MatLyLu prostate cancer cells correlates with vascular endothelial growth factor inhibition. Cancer Res 2006;66:5599-5607. (Pubitemid 43927110)
38. Smeets B, Kuppe C, Sicking E, et al. Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis. J Am Soc Nephrol 2011;22:1262-1274.